Bimetallic Nanozyme Amplifier for Synergistic Ferroptosis‐Cuproptosis and Metabolic Reprogramming to Reshape Immunosuppressive Tumor Microenvironment
Advanced Science · 2026
DOI: 10.1002/advs.202512764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Jianzhang Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Department, The Affiliated Hospital of Guilin Medical University, Lequn road No.15, Xiufeng district, Guilin, 541001, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Ferroptosis, Metal Nanoparticles, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Huatong Guokang Public Welfare Foundation, Beijing, Guangxi Science and Technology Bases and Talent Special Program.
Abstract (Originalsprache)
Although ferroptosis and cuproptosis have shown potential in tumor therapy, their anti‐tumor efficacy remains considerably limited due to aberrant metabolism within tumor cells and the immunosuppressive tumor microenvironment (TME). Herein, metal–organic framework nanoparticles (PEG@AuCZ@CC) are engineered by incorporating Au nanoparticles and α‐Cyano‐4‐hydroxycinnamic acid (CHCA), to maximize hydrogen peroxide production and induce metabolic shift from aerobic glycolysis to oxidative phosphorylation in tumor cells. Interestingly, metabolic reprogramming of tumor cells not only enhances both ferroptotic and cuproptotic signaling cascades, amplifies immunogenic cell death (ICD) effects, but also reduces intratumoral glucose consumption and extracellular lactate accumulation, thereby creating a glucose‐enriched but lactate‐depleted TME. Consequently, the platform significantly promotes dendritic cells maturation, enables epigenetic reprogramming of tumor‐associated macrophages (TAMs), and restores CD4⁺/CD8⁺ T‐cells functionality. This multimodal strategy reshapes the tumor microenvironment (TME) by integrating cell death modulation and cell metabolism regulation, effectively overcoming immune tolerance, presenting a promising paradigm for hepatocellular carcinoma (HCC) therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Digestive Department, The Affiliated Hospital of Guilin Medical University, Lequn road No.15, Xiufeng district, Guilin, 541001, China.
- Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
ORCID-Profile: Duo Wang, Liyan Wang
Förderung
- National Natural Science Foundation of China
- Huatong Guokang Public Welfare Foundation, Beijing
- Guangxi Science and Technology Bases and Talent Special Program
Zitieren
APA
Luo, J., Huang, K., Yi, X., Lu, P., Xie, H., Li, W., Zeng, Q., He, F., Wang, D., & Wang, L. (2026). Bimetallic Nanozyme Amplifier for Synergistic Ferroptosis‐Cuproptosis and Metabolic Reprogramming to Reshape Immunosuppressive Tumor Microenvironment. Advanced Science. https://doi.org/10.1002/advs.202512764
Vancouver
Luo J, Huang K, Yi X, Lu P, Xie H, Li W, et al. Bimetallic Nanozyme Amplifier for Synergistic Ferroptosis‐Cuproptosis and Metabolic Reprogramming to Reshape Immunosuppressive Tumor Microenvironment. Advanced Science. 2026. doi:10.1002/advs.202512764
BibTeX
@article{Luo2026,
author = {Luo, Jianzhang and Huang, Kunzhao and Yi, Xiaoyuan and Lu, Pei and Xie, Huaying and Li, Wen and Zeng, Qingyu and He, Feifei and Wang, Duo and Wang, Liyan},
title = {Bimetallic Nanozyme Amplifier for Synergistic Ferroptosis‐Cuproptosis and Metabolic Reprogramming to Reshape Immunosuppressive Tumor Microenvironment},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202512764}
}
EUVIMED